Consequently, genetically modified xenograft models (SCD gene knockdown or overexpression), as well as pharmaceutical inhibition of SCD activity, are commonly used to study the role of this enzyme family in tumor development and progression (see Table 3). This evidence concerns the gene SCD and neoplasm.